ZetaRx Biosciences
Latest round
- Series B
Last raised
- Dec 2012
Total raised
- $1.8M
Investors
- 2
About ZetaRx Biosciences
Founded in 2009 and based in Washington, US, ZetaRx Biosciences, Inc. operates as a biotechnology company that develops immunotherapies for the treatment of cancer.
Who invested in ZetaRx Biosciences
2 investors across 1 round
See all investors in ZetaRx Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 7, 2012
Amount
$1.8M
Investors
Questions about ZetaRx Biosciences
Who invested in ZetaRx Biosciences?
ZetaRx Biosciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ZetaRx Biosciences raised?
ZetaRx Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ZetaRx Biosciences last raise money?
ZetaRx Biosciences's most recent round on record is a Series B, in Dec 2012.
What does ZetaRx Biosciences do?
Founded in 2009 and based in Washington, US, ZetaRx Biosciences, Inc.
Where is ZetaRx Biosciences headquartered?
ZetaRx Biosciences is headquartered in Seattle, US.
Which VCs invest in companies like ZetaRx Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ZetaRx Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ZetaRx Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.